Moxisylyte
From Infogalactic: the planetary knowledge core
Jump to: navigation, search
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
4-[2-(Dimethylamino)ethoxy]-5-isopropyl-2-methylphenyl acetate
|
|
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| CAS Number | 54-32-0  Y |
| ATC code | G04BE06 (WHO) C04AX10 |
| PubChem | CID: 4260 |
| ChemSpider | 4110 |
| UNII | PW8QYA7KI0 Y |
| KEGG | D08239 Y |
| Chemical data | |
| Formula | C16H25NO3 |
| Molecular mass | 279.375 g/mol |
|
|
|
|
| (verify) | |
Moxisylyte, also known as thymoxamine, is a drug used in urology for the treatment of erectile dysfunction.[1] It is an α1-adrenergic antagonist.[2]
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references> tag; parameter "group" is allowed only.
<references />, or <references group="..." />| Phenylethanolamine derivatives | |
|---|---|
| Imidazoline derivatives Alpha blockers |
|
| Niacin and derivatives | |
| Purine derivatives | |
| Ergot alkaloids | |
| Other peripheral vasodilators | |
| For erectile dysfunction |
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| For premature ejaculation |
|
||||||||||||
|
|||||||||||||
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
Categories:
- Pages with reference errors
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Phenol ethers
- Acetate esters
- Cardiovascular system drug stubs
- Genito-urinary system drug stubs
